Literature DB >> 10881099

[Congenital Chagas-Mazza disease in Salta, Argentina].

S Contreras1, M R Fernandez, F Agüero, J Desse Desse, T Orduna, O Martino.   

Abstract

A study was carried out on T. cruzi infection in pregnant women in the Guemes area in Salta province; the rate of infection was 12.3%. Of newborn children studied by the microhematocrit technique, 8.8% were diagnosed with Chagas' disease. All of them were treated with benznidazol (5mg/kg/day) for one month; all of them presented anemia, which was interpreted to be an adverse drug reaction. The microhematocrit technique is believed to represent the best option for diagnosis of this disease in newborn children. A diagnostic methodology to follow the course of the infection is proposed.

Entities:  

Mesh:

Year:  1999        PMID: 10881099     DOI: 10.1590/s0037-86821999000600004

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

1.  Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina.

Authors:  Ana María De Rissio; Adelina Rosa Riarte; Miriam Martín García; Mónica Inés Esteva; Marta Quaglino; Andrés Mariano Ruiz
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Newborn screening for congenital infectious diseases.

Authors:  Eurico Camargo Neto; Rosélia Rubin; Jacqueline Schulte; Roberto Giugliani
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

Review 3.  Chagas' disease: pregnancy and congenital transmission.

Authors:  Ana María Cevallos; Roberto Hernández
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

4.  Risk factors associated with Chagas disease in pregnant women in Santander, a highly endemic Colombian area.

Authors:  Yeny Z Castellanos-Domínguez; Zulma M Cucunubá; Luis C Orozco; Carlos A Valencia-Hernández; Cielo M León; Astrid C Florez; Lyda Muñoz; Paula Pavía; Marleny Montilla; Luz Marina Uribe; Carlos García; William Ardila; Rubén Santiago Nicholls; Concepción J Puerta
Journal:  Trop Med Int Health       Date:  2015-12-01       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.